跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
易来克 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Belumosudil Mesylate Tablets
Approved
化学药品
Belumosudil Mesylate Tablets
Kadmon Pharmaceuticals, LLC
🇨🇳 National Medical Products Administration
Approval Date
Aug 1, 2023
Approval ID
8TELoNJ3vbN
Company
Kadmon Pharmaceuticals, LLC
Type
化学药品
Approval Details
Approval Id
8TELoNJ3vbN
Approval Number
国药准字HJ20230095
Generic Name
甲磺酸贝舒地尔片
Generic Name En
Belumosudil Mesylate Tablets
Trade Name
易来克
Drug Type
化学药品
Dosage Form
片剂
Strength
0.2g(按C₂₆H₂₄N₆O₂计)
Reg Date
2023-08-01
Expired Date
2028-07-31
Company Name
Kadmon Pharmaceuticals, LLC
Production Company Name
UPM Pharmaceuticals, Inc.
Company Detail Path
/organization/kadmon-pharmaceuticals-llc
Production Company Detail Path
/organization/upm-pharmaceuticals-inc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 1, 2023
Approval ID
8TELoNJ3vbN
Type
化学药品
Back to NMPA Approvals